Works by Zhenya Hong

Results: 23

Macrophage, the potential key mediator in CAR-T related CRS.

Published in:

Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00171-5

By:

Hao, Zhaonian;
Li, Ruyuan;
Meng, Li;
Han, Zhiqiang;
Hong, Zhenya

Publication type:

Article

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01360-x

By:

Li, Shuangying;
Wang, Liangliang;
Wang, Yuanyuan;
Zhang, Changyi;
Hong, Zhenya;
Han, Zhiqiang

Publication type:

Article

Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1036511

By:

Kefeng Shen;
Meilan Zhang;
Jiachen Wang;
Wei Mu;
Jin Wang;
Chunyan Wang;
Shugang Xing;
Zhenya Hong;
Min Xiao

Publication type:

Article

Corrigendum to: A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity.

Published in:

Carcinogenesis, 2020, v. 41, n. 2, p. 247, doi. 10.1093/carcin/bgz202

By:

Han, Zhiqiang;
Hong, Zhenya;
Chen, Caihong;
Gao, Qinglei;
Luo, Danfeng;
Fang, Yong;
Cao, Yang;
Zhu, Tao;
Jiang, Xuefeng;
Ma, Quanfu;
Li, Wei;
Han, Lingfei;
Wang, Daowen;
Xu, Gang;
Wang, Shixuan;
Meng, Li;
Zhou, Jianfeng;
Ma, Ding

Publication type:

Article

Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation.

Published in:

Carcinogenesis, 2011, v. 32, n. 10, p. 1550, doi. 10.1093/carcin/bgr176

By:

Hong, Zhenya;
Xiao, Min;
Yang, Yang;
Han, Zhiqiang;
Cao, Yang;
Li, Chunrui;
Wu, Ying;
Gong, Quan;
Zhou, Xiaoxi;
Xu, Danmei;
Meng, Li;
Ma, Ding;
Zhou, Jianfeng

Publication type:

Article

A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity.

Published in:

Carcinogenesis, 2009, v. 30, n. 12, p. 2014, doi. 10.1093/carcin/bgp249

By:

Zhiqiang Han;
Zhenya Hong;
Caihong Chen;
Qinglei Gao;
Danfeng Luo;
Yong Fang;
Yang Cao;
Tao Zhu;
Xuefeng Jiang;
Quanfu Ma;
Wei Li;
Lingfei Han;
Daowen Wang;
Gang Xu;
Shixuan Wang;
Li Meng;
Jianfeng Zhou;
Ding Ma

Publication type:

Article

Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review.

Published in:

Infection & Drug Resistance, 2020, v. 13, p. 3309, doi. 10.2147/IDR.S267997

By:

Peng, Yizhou;
Meng, Li;
Hu, Xuemei;
Han, Zhiqiang;
Hong, Zhenya

Publication type:

Article

Superresolution Fluorescence Microscopy of Platelet Subcellular Structures as a Potential Tumor Liquid Biopsy.

Published in:

Small Methods, 2023, v. 7, n. 10, p. 1, doi. 10.1002/smtd.202300445

By:

Xu, Peng;
Deng, Huan;
Hong, Zhenya;
Zhong, Simei;
Chen, Feifan;
Wang, Liangliang;
Wang, Zhenhao;
Mei, Yu;
Luo, Ziying;
He, Ziliang;
Li, Haiwen;
Gan, Chao;
Zhang, Huaqiu;
Ma, Yan;
Han, Zhiqiang;
Zhang, Yu‐Hui

Publication type:

Article

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends.

Published in:

Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01522-4

By:

Sun, Qian;
Hong, Zhenya;
Zhang, Cong;
Wang, Liangliang;
Han, Zhiqiang;
Ma, Ding

Publication type:

Article

Clinical Responses and Pharmacokinetics of fully human BCMA Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e23, doi. 10.1016/j.clml.2019.09.034

By:

Li, Chunrui;
Zhou, Xiaoxi;
Wang, Jue;
Hu, Guang;
yang, yongkun;
Meng, Li;
Hong, Zhenya;
Chen, Liting;
Zhou, Jianfeng

Publication type:

Article

Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Expert Review of Hematology, 2024, v. 17, n. 4/5, p. 173, doi. 10.1080/17474086.2024.2343885

By:

Peng, Yizhou;
Huang, Jinjin;
Yin, Jin;
Meng, Fankai;
Cao, Yang;
Huang, Liang;
Li, Dengju;
Zhang, Yicheng;
Zhang, Donghua;
Meng, Li;
Han, Zhiqiang;
Hong, Zhenya

Publication type:

Article

Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02145-9

By:

Zhou, Hao;
Liu, Wei;
Zhou, Yongming;
Hong, Zhenya;
Ni, Jian;
Zhang, Xiaoping;
Li, Ziping;
Li, Mengyuan;
He, Wenjuan;
Zhang, Donghua;
Chen, Xuexing;
Zhu, Jianhua

Publication type:

Article

The efficacy and safety of eltrombopag in treating TKI-induced thrombocytopenia in patients with chronic myeloid leukemia.

Published in:

Hematology, 2023, v. 28, n. 1, p. 1, doi. 10.1080/16078454.2023.2248434

By:

Liu, Li;
Chen, Yilin;
Liang, Yan;
Meng, Li;
Guo, Jingming;
Liu, Chuancai;
Zhao, Zhe;
Zou, Jing;
He, Wenjuan;
Zhang, Jiangzhao;
Hong, Zhenya;
Liang, Caixia;
Fu, Xianjie;
Wu, Hui;
Zhang, Youshan;
Zhang, Yanli;
Li, Weiming

Publication type:

Article

Cervical cancer heterogeneity: a constant battle against viruses and drugs.

Published in:

Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00428-7

By:

Sun, Qian;
Wang, Liangliang;
Zhang, Cong;
Hong, Zhenya;
Han, Zhiqiang

Publication type:

Article

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.

Published in:

2022

By:

Hao, Zhaonian;
Li, Ruyuan;
Wang, Yuanyuan;
Li, Shuangying;
Hong, Zhenya;
Han, Zhiqiang

Publication type:

Correction Notice

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.

Published in:

Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00333-5

By:

Hao, Zhaonian;
Li, Ruyuan;
Wang, Yuanyuan;
Li, Shuangying;
Hong, Zhenya;
Han, Zhiqiang

Publication type:

Article

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.

Published in:

Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00333-5

By:

Hao, Zhaonian;
Li, Ruyuan;
Wang, Yuanyuan;
Li, Shuangying;
Hong, Zhenya;
Han, Zhiqiang

Publication type:

Article

Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN.

Published in:

Frontiers in Genetics, 2023, p. 1, doi. 10.3389/fgene.2023.1198834

By:

Jin Zhang;
Kefeng Shen;
Min Xiao;
Jinjin Huang;
Jin Wang;
Yaqin Wang;
Zhenya Hong

Publication type:

Article

Effectiveness and safety of nab- paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e44

By:

Liangliang Wang;
Shuangying Li;
Da Zhu;
Yu Qin;
Xiaoli Wang;
Zhenya Hong;
Zhiqiang Han

Publication type:

Article

MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation.

Published in:

Cell Death Discovery, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41420-020-00342-7

By:

Craig, Jane E.;
Miller, Joseph N.;
Rayavarapu, Raju R.;
Hong, Zhenya;
Bulut, Gamze B.;
Zhuang, Wei;
Sakurada, Sadie Miki;
Temirov, Jamshid;
Low, Jonathan A.;
Chen, Taosheng;
Pruett-Miller, Shondra M.;
Huang, Lily Jun-shen;
Potts, Malia B.

Publication type:

Article

TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369346

By:

Zhenhao Wang;
Yu Mei;
Zhuming Yang;
Qiang Gao;
Hao Xu;
Zhiqiang Han;
Zhenya Hong

Publication type:

Article

Efficient 3D imaging and pathological analysis of the human lymphoma tumor microenvironment using light-sheet immunofluorescence microscopy.

Published in:

Theranostics, 2024, v. 14, n. 1, p. 406, doi. 10.7150/thno.86221

By:

Liting Chen;
Jiao Meng;
Yao Zhou;
Fang Zhao;
Yifan Ma;
Wenyang Feng;
Xingyu Chen;
Jin jin;
Shimeng Gao;
Jianchao Liu;
Man Zhang;
Aichun Liu;
Zhenya Hong;
Jiang Tang;
Dong Kuang;
Liang Huang;
Yicheng Zhang;
Peng Fei

Publication type:

Article

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 3, p. 1, doi. 10.1002/ctm2.346

By:

Li, Chunrui;
Cao, Wenyue;
Que, Yimei;
Wang, Qiuxiang;
Xiao, Yi;
Gu, Chaojiang;
Wang, Di;
Wang, Jue;
Jiang, Lijun;
Xu, Hao;
Xu, Jinhuan;
Zhou, Xiaoxi;
Hong, Zhenya;
Wang, Na;
Huang, Liang;
Zhang, Shangkun;
Chen, Liting;
Mao, Xia;
Xiao, Min;
Zhang, Wei

Publication type:

Article